Cetera Investment Advisers’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Sell |
7,927
-97
| -1% | -$27.9K | ﹤0.01% | 1749 |
|
|
2025
Q1 | $2.47M | Sell |
8,024
-691
| -8% | -$213K | ﹤0.01% | 1593 |
|
|
2024
Q4 | $3.08M | Buy |
8,715
+463
| +6% | +$163K | 0.01% | 1342 |
|
|
2024
Q3 | $2.96M | Buy |
8,252
+2,085
| +34% | +$747K | 0.01% | 1335 |
|
|
2024
Q2 | $1.96M | Buy |
6,167
+493
| +9% | +$157K | ﹤0.01% | 1589 |
|
|
2024
Q1 | $1.3M | Buy |
5,674
+3,015
| +113% | +$693K | ﹤0.01% | 1870 |
|
|
2023
Q4 | $585K | Buy |
2,659
+197
| +8% | +$43.3K | ﹤0.01% | 1408 |
|
|
2023
Q3 | $556K | Buy |
2,462
+210
| +9% | +$47.4K | ﹤0.01% | 1363 |
|
|
2023
Q2 | $497K | Buy |
2,252
+295
| +15% | +$65.1K | ﹤0.01% | 1454 |
|
|
2023
Q1 | $438K | Buy |
1,957
+6
| +0.3% | +$1.34K | ﹤0.01% | 1505 |
|
|
2022
Q4 | $543K | Buy |
1,951
+792
| +68% | +$220K | 0.01% | 1328 |
|
|
2022
Q3 | $243K | Buy |
1,159
+203
| +21% | +$42.6K | ﹤0.01% | 1403 |
|
|
2022
Q2 | $225K | Buy |
+956
| New | +$225K | ﹤0.01% | 1603 |
|